Regeneca commences manufacturing of RegenErect
RegenErect is a natural herbal supplement designed to enhance sexual experience and intimacy between couples. Regeneca CEO Matt Nicosia said they are happy with the progress that has
Teva Pharmaceuticals International has made a bid to acquire a range of neuroscience assets from BioXcel Therapeutics for a total deal value of $125m.